vitiligo

Patient Buzz Series: Skin Bias in Dermatology
Skin bias in dermatologyThe topic of disparities in the dermatologic care of skin of color is now receiving national attention in the consumer press. Articles in this month’s Patient Buzz address questions, including: Is skin bias in dermatology endangering people of color? Why are dermatology images not more diverse? What should Black patients know before their next dermatology visit? Don’t be caught off guard wi …
Skin bias in dermatology
Current and Emerging Management Strategies for Vitiligo
vitiligoVitiligo is an autoimmune skin disease that affects >3 million individuals in the US and around 74 million worldwide. In addition to physical symptoms such as itch, it can be particularly cosmetically concerning and psychologically distressing. It mainly affects young individuals, where it is estimated that 50% of cases have onset before the age of 20. Importantly, it is associated with other a …
vitiligo
What’s New on the Vitiligo Treatment Horizon
New Vitiligo TreatmentsNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. John Harris, Vice-Chair of Dermatology and Director of the Vitiligo Clinic and Research Center at UMass Medical School in Worcester, Massachusetts, on new vitiligo treatments in the horizon. Watch as he shares recent discoveries that have influenced the way that we diagnose and manage pat …
New Vitiligo Treatments
Inhibiting the JAK/STAT Pathway to Treat Inflammatory Skin Diseases
JAK InhibitorsNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Jonathan Zippin, Vice-Chair of Research and an Associate Attending Dermatologist and Associate Professor of Dermatology at Weill Medical College of Cornell, and Director of the Contact, Occupational and Photodermatitis Service. Watch as he reviews the JAK/STAT signaling pathway in normal i …
JAK Inhibitors